Keystone Epitope Theory: Implications for Hypersensitivity, Autoimmunity, and Transplantation

Area of Science:

• Immunology
• Infectious Diseases
• Pharmacology

Background:

• Human Leukocyte Antigen (HLA) class I alleles are associated with T cell-mediated drug hypersensitivity, but predictive values are low.
• Persistent pathogens, particularly herpesviruses, may imprint immune memory on conserved epitopes within specific tissue niches.
• This co-evolutionary relationship between hosts and viruses is replayed during individual development, shaping tissue-specific immune memory.

Purpose of the Study:

• To propose the Keystone Epitope Theory, explaining how persistent infections influence drug hypersensitivity.
• To investigate the role of pre-existing tissue-resident memory T cells (TRM) in drug-induced immunopathology.
• To extend this framework to other T cell-mediated conditions like multiple sclerosis and transplant rejection.

Main Methods:

• Synthesizing evidence from heterologous immunity, where virus-imprinted TRM cross-recognize drug-modified self-peptides.
• Analyzing antigen presentation within tissues where antiviral memory resides to explain tissue-specific injury.
• Examining T cell receptor (TCR) structures that bridge viral and self-targets.

Main Results:

• Drug-altered self-peptides presented by risk HLA alleles can trigger pre-existing TRM responses.
• This recruitment of TRM can disrupt local immune regulation, leading to immunopathology.
• The framework explains tissue restriction of injury and links viral imprinting to drug hypersensitivity.

Conclusions:

• The Keystone Epitope Theory provides a novel explanation for T cell-mediated drug hypersensitivity.
• This model extends to conditions such as EBV-associated multiple sclerosis and transplant rejection.
• Proposed experimental strategies can validate this framework for broader T cell-mediated hypersensitivity and autoimmunity research.